Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker-Based Strategy—Authors' Reply

Simple item page
dc.contributor.authorSaeoui T.
dc.contributor.authorKositamongkol C.
dc.contributor.authorPhisalprapa P.
dc.contributor.authorKaewdech A.
dc.contributor.correspondenceSaeoui T.
dc.contributor.otherMahidol University
dc.date.accessioned2025-10-21T18:15:04Z
dc.date.available2025-10-21T18:15:04Z
dc.date.issued2025-01-01
dc.identifier.citationAlimentary Pharmacology and Therapeutics (2025)
dc.identifier.doi10.1111/apt.70422
dc.identifier.eissn13652036
dc.identifier.issn02692813
dc.identifier.pmid41084232
dc.identifier.scopus2-s2.0-105018716687
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/112698
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleEditorial: Advancing HCC Surveillance in Hepatitis B With Biomarker-Based Strategy—Authors' Reply
dc.typeEditorial
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105018716687&origin=inward
oaire.citation.titleAlimentary Pharmacology and Therapeutics
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationFaculty of Medicine, Prince of Songkla University

Files

Collections

Scopus 2025